ArticleMethods in molecular biology (Clifton, N.J.)2026
Preparation of Lentiviral Vectors for the Generation of Transgenic Cynomolgus Monkeys.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonhuman primates (NHPs) are invaluable for modeling human diseases because of their high physiological and genetic similarity to humans. Lentiviral vectors, which offer significant advantages in terms of gene delivery and stable in vivo expression, are widely used to generate transgenic NHP models. The protocol detailed herein provides a comprehensive method for preparing lentiviral vectors for the generation of transgenic cynomolgus monkeys. We describe the procedures for packaging lentiviral vectors, including the transfection and enrichment of lentiviral particles. To optimize lentiviral production and ensure high-titer viral preparations, we utilized Sendai virus hemagglutinin-neuraminidase glycoproteins to enhance infection efficiency. This protocol is designed to support the production of high-quality lentiviral vectors, which are essential for achieving robust, uniform transgene expression in transgenic cynomolgus monkeys to advance human disease modeling and therapeutic research.
Indexed as
Identifiers
41273641What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.